Literature DB >> 17207921

GATA transcription factors in adrenal development and tumors.

Helka Parviainen1, Sanne Kiiveri, Malgorzata Bielinska, Nafis Rahman, Ilpo T Huhtaniemi, David B Wilson, Markku Heikinheimo.   

Abstract

Of the six GATA transcription factors, GATA-4 and GATA-6 are expressed in the mouse and human adrenal with distinct developmental profiles. GATA-4 is confined to the fetal cortex, i.e. to the less differentiated proliferating cells, while GATA-6 is expressed both in the fetal and adult adrenal. In vitro, GATA-4 regulates inhibin-alpha and steroidogenic factor-1 implicated in normal adrenal function. GATA-6 probably has roles in the development and differentiation of adrenocortical cells, and in the regulation of steroidogenesis. GATA-4 expression is dramatically upregulated and GATA-6 downregulated in gonadotropin dependent mouse adrenocortical tumors. This is accompanied by the appearance of luteinizing hormone receptor (LHR). In vitro, GATA-4 transactivates LHR promoter, and gonadotropins upregulate GATA-4 levels. Human adrenal tumors occasionally express GATA-4, whereas GATA-6 levels are usually lower than normal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17207921     DOI: 10.1016/j.mce.2006.12.033

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  7 in total

Review 1.  Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit.

Authors:  Hitoshi Ishimoto; Robert B Jaffe
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

Review 2.  Review paper: origin and molecular pathology of adrenocortical neoplasms.

Authors:  M Bielinska; H Parviainen; S Kiiveri; M Heikinheimo; D B Wilson
Journal:  Vet Pathol       Date:  2009-03       Impact factor: 2.221

3.  EGF is required for cardiac differentiation of P19CL6 cells through interaction with GATA-4 in a time- and dose-dependent manner.

Authors:  Cai-Xia Ma; Yang-Liu Song; Liyun Xiao; Li-Xiang Xue; Wen-Juan Li; Brigitte Laforest; Hiba Komati; Wei-Ping Wang; Zhu-Qing Jia; Chun-Yan Zhou; Yunzeng Zou; Mona Nemer; Shan-Feng Zhang; Xiaowen Bai; Huijian Wu; Ming-Xi Zang
Journal:  Cell Mol Life Sci       Date:  2014-12-14       Impact factor: 9.261

4.  GATA4 is a critical regulator of gonadectomy-induced adrenocortical tumorigenesis in mice.

Authors:  Justyna Krachulec; Melanie Vetter; Anja Schrade; Ann-Kathrin Löbs; Malgorzata Bielinska; Rebecca Cochran; Antti Kyrönlahti; Marjut Pihlajoki; Helka Parviainen; Patrick Y Jay; Markku Heikinheimo; David B Wilson
Journal:  Endocrinology       Date:  2012-03-28       Impact factor: 4.736

5.  Cushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice.

Authors:  Isabelle Sahut-Barnola; Cyrille de Joussineau; Pierre Val; Sarah Lambert-Langlais; Christelle Damon; Anne-Marie Lefrançois-Martinez; Jean-Christophe Pointud; Geoffroy Marceau; Vincent Sapin; Frédérique Tissier; Bruno Ragazzon; Jérôme Bertherat; Lawrence S Kirschner; Constantine A Stratakis; Antoine Martinez
Journal:  PLoS Genet       Date:  2010-06-10       Impact factor: 5.917

Review 6.  Complex assembly on the human CYP17 promoter.

Authors:  Marion B Sewer; Srinath Jagarlapudi
Journal:  Mol Cell Endocrinol       Date:  2008-10-19       Impact factor: 4.102

7.  MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans.

Authors:  Claire R Hughes; Leonardo Guasti; Eirini Meimaridou; Chen-Hua Chuang; John C Schimenti; Peter J King; Colm Costigan; Adrian J L Clark; Louise A Metherell
Journal:  J Clin Invest       Date:  2012-02-22       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.